Tesamorelin

Tesamorelin is a GHRH analogue studied for its targeted ability to reduce visceral adipose tissue and improve metabolic markers.

• May support targeted reduction of visceral (belly) fat
• Studied for improvements in lipid profiles and metabolic markers
• Research suggests potential cognitive health benefits
• Potential role in cardiovascular risk reduction

For research purposes only. Not intended for human consumption, veterinary use, or any purpose other than in vitro scientific research. These statements have not been evaluated by the FDA.